지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2025.1
- 수록면
- 11 - 17 (7page)
이용수
초록· 키워드
오류제보하기
This review highlights the current and emerging pharmacological treatments for attention-deficit/hyperactivity disorder. Stimulants such as methylphenidate are the first-line treatment for improving attention and behavior. Non-stimulants, such as atomoxetine serve as alternative options, particularly for patients with comorbid conditions or those intolerant to stimulants. Emerging treatments, not yet available in Korea, include the methylphenidate prodrug, delayed-release/extended-release methylphenidate, and transdermal dextroamphetamine, that provide innovative delivery systems for sustained symptom control. Additionally, novel drugs such as viloxazine and centanafadine show promise as alternatives with potentially fewer side effects, broadening the spectrum of available therapies. As these new medications become accessible, they may help develop more personalized treatment plans tailored to individual patient needs and potential side effects.
목차
INTRODUCTION
PHARMACOLOGICAL TREATMENTS FOR ADHD IN KOREA
NEW TREATMENT OPTIONS FOR ADHD
CONCLUSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children
Clinical and Experimental Pediatrics
2019 .01
-
Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder
Clinical Psychopharmacology and Neuroscience
2021 .11
-
Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
소아청소년정신의학
2022 .04
-
Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database
Journal of Korean Medical Science
2016 .01
-
주의력결핍과잉행동장애의 약물요법
대한의사협회지
2019 .01
-
Emerging Breakthroughs in Pediatric Attention-Deficit/ Hyperactivity Disorder Treatment
소아청소년정신의학
2025 .01
-
Health Status, Physical Diseases, and Injuries in Children with Attention-Deficit/Hyperactivity Disorder
대한소아청소년정신의학회 학술대회논문집
2017 .05
-
국내 주의력결핍 과잉행동 장애 아동 및 청소년의 약물요법 패턴 및 지속성
한국임상약학회지
2018 .01
-
주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(Ⅲ) : 약물치료
소아청소년정신의학
2017 .04
-
Decreased Brain Surface Complexity in Children With Attention Deficit Hyperactivity Disorder
Journal of Clinical Neurology
2022 .01
-
Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
Clinical Psychopharmacology and Neuroscience
2020 .01
-
The Effectiveness of Methylphenidate in the Treatment of Encopresis Independent from Attention-Deficit Hyperactivity Disorder Symptoms
PSYCHIATRY INVESTIGATION
2015 .01
-
A Rare Phenomenon, Recurrent Acute Dystonia after Withdrawal of ‘Methylphenidate-immediate Release Form’: A Pediatric Case with ADHD
Clinical Psychopharmacology and Neuroscience
2024 .08
-
소아 주의력결핍 및 과잉행동장애 (ADHD)의 한의학적 치료에 대한 국내외 연구 동향
대한한방소아과학회지
2019 .01
-
Effects of Iron Supplementation on Attention Deficit Hyperactivity Disorder in Children Treated with Methylphenidate
Clinical Psychopharmacology and Neuroscience
2021 .11
-
Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
Clinical Psychopharmacology and Neuroscience
2016 .01
-
(Erratum) The Positive Aspects of Attention-Deficit/Hyperactivity Disorder among Famous People
PSYCHIATRY INVESTIGATION
2020 .01
-
국민건강보험 데이터베이스를 이용한 한국의 소아와 성인에서 주의력결핍 과잉행동장애의 진단율 및 약물 사용 추세 연구
신경정신의학
2021 .11
-
A Brief Replication Study Comparing Stimulants and Non-Stimulants for Attention-Deficit/Hyperactivity Disorder Treatment with a Focus on the Compliance, Efficacy, and Satisfaction
소아청소년정신의학
2021 .01
-
Robot Motion Tracking Analysis in Attention-Deficit/Hyperactivity Disorder
대한소아청소년정신의학회 학술대회논문집
2017 .05
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-25-02-092381586